• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Catherine Makino

Articles by Catherine Makino

Asia in the Spotlight: Japanese companies look to ASEAN, Lat Am for growth

March 9, 2015
By Catherine Makino

Eisai, Merck team up for pembrolizumab combo cancer trials

March 6, 2015
By Catherine Makino
TOKYO – Japan's Eisai Co. Ltd. will work with multinational Merck & Co. Inc. to jointly develop combination cancer regimens.
Read More

GHIT's Grand Challenge funds new approaches to infectious diseases

Feb. 25, 2015
By Catherine Makino
TOKYO –Japan's Global Health Innovative Technology Fund (GHIT Fund), which works with several Japanese ministries, pharmaceutical companies and other nonprofit organizations, such as the United Nations Development Program and the Bill & Melinda Gates Foundation, launched a "Grand Challenge" that will see it invest up to $1 million per applicant "for the early stage development of radically new and improved drugs, vaccines or diagnostics to prevent and treat infectious diseases that are prevalent in developing countries."
Read More

GHIT's Grand Challenge funds new approaches to infectious diseases

Feb. 17, 2015
By Catherine Makino
TOKYO –Japan's Global Health Innovative Technology Fund (GHIT Fund), which works with several Japanese ministries, pharmaceutical companies and other nonprofit organizations, such as the United Nations Development Program and the Bill & Melinda Gates Foundation, launched a "Grand Challenge" that will see it invest up to $1 million per applicant "for the early stage development of radically new and improved drugs, vaccines or diagnostics to prevent and treat infectious diseases that are prevalent in developing countries."
Read More

PMDA reaping rewards of policy changes with rising approval rates

Feb. 5, 2015
By Catherine Makino
TOKYO – Thanks to a series of policy initiatives, Japan's Pharmaceutical and Medical Device Agency (PMDA) has morphed into a much more nimble regulator, one that processes approvals as fast as the FDA or the EMA.
Read More

PMDA reaping rewards of policy changes with rising approval rates

Feb. 4, 2015
By Catherine Makino
TOKYO – Thanks to a series of policy initiatives, Japan's Pharmaceutical and Medical Device Agency (PMDA) has morphed into a much more nimble regulator, one that processes approvals as fast as the FDA or the EMA.
Read More

Asia in the Spotlight: Robots filling anti-cancer prescriptions in Japan

Feb. 2, 2015
By Catherine Makino

Asia in the spotlight: Medigus receives patent for miniature high res ScoutCam

Jan. 22, 2015
By Catherine Makino

Lilly, Boehringer win first Japanese nod for insulin biosimilar

Jan. 21, 2015
By Catherine Makino
TOKYO – Biosimilar insulin products have received regulatory approval in Japan for the first time ever.
Read More

Lilly, Boehringer win first Japanese nod for insulin biosimilar

Jan. 21, 2015
By Catherine Makino
TOKYO – Biosimilar insulin products have received regulatory approval in Japan for the first time ever.
Read More
Previous 1 2 3 4 5 6 7 8 9 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 28, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 27, 2025.
  • Biotech deal illustration

    City hits the town with $1B-plus deal with Biogen

    BioWorld
    A development deal with Biogen Inc. could eventually bring City Therapeutics Inc. about $1 billion in milestone payments. It’s a step in the direction the company...
  • Salvia Bioelectronics MySalvia implant

    Salvia raises $60M for neuromodulation migraine system

    BioWorld MedTech
    Salvia Bioelectronics BV raised $60 million in a series B financing round for its minimally invasive implantable neuromodulation device, Mysalvia therapy, which...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 27, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe